C32H52O5, monoclinic, P21 (no. 4), a = 11.816(2) Å, b = 7.4064(15) Å, c = 17.101(3) Å, β = 97.01(3)°, V = 1485.5(5) Å3, Z = 2, Rgt(F) = 0.0543, wRref(F2) = 0.1501, T = 293(2) K
C15H16O2, triclinic, P1̄ (no. 2), a = 5.6034(7) Å, b = 8.7105(11) Å, c = 12.5661(16) Å, α = 92.790(7...
5α-cyano-3-keto-10-methyl-octahydronaphthalene, C12H17NO, crystallizes in monoclinic space group P2...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....
C30H52O3, orthorhombic, P212121 (no. 19), a = 6.71147(14) Å, b = 16.6565(4) Å, c = 25.0815(6) Å, V =...
C33H41N3O2, orthorhombic, P212121 (no. 19), a = 8.44861(4) Å, b = 17.00722(9) Å, c = 20.1555(1) Å, V...
C29H54N2O3, monoclinic, P21 (no. 4), a = 9.8091(11) Å, b = 7.6661(8) Å, c = 19.095(2) Å, β = 93.171(...
The title compound, C30H48O2, contains a fused four-ring triterpenoid system. In the molecule, the t...
C24H18O3, monoclinic, P21/c (no. 14), a = 9.0474(7) Å, b = 19.9648(12) Å, c = 10.7153(3) Å, β = 104....
C17H20O2, monoclinic, P121/n1 (no. 14), a = 6.618(1) Å, b = 27.538(5) Å, c = 14.951(3) Å, β = 98.768...
C15H16O, monoclinic, P21/c (no. 14), a = 5.4371(7) Å, b = 17.567(2) Å, c = 11.8840(18) Å, β = 101.04...
C28H36FNO2, orthorhombic, P212121 (no. 19), a = 6.3277(3) Å, b = 11.9665(19) Å, c = 32.2419(19) Å, V...
C18H16O2, orthorhombic, Pnma (no. 62), a = 14.474(6) Å, b = 6.815(3) Å, c = 13.738(6) Å, V = 1355.1(...
C20H26O5, monoclinic, P21 (no. 4), a = 7.0011(5) Å, b = 12.3136(9) Å, c = 10.4847(8) Å, β = 105.734(...
C31H48O5, monoclinic, P21 (no. 4), a = 11.0421(3) Å, b = 6.49710(16) Å, c = 20.4687(4) Å, β = 97.922...
C32H50O3, orthorhombic, P212121 (no. 19), a = 8.0417(5) Å, b = 11.7996(6) Å, c = 30.1631(16) Å, V = ...
C15H16O2, triclinic, P1̄ (no. 2), a = 5.6034(7) Å, b = 8.7105(11) Å, c = 12.5661(16) Å, α = 92.790(7...
5α-cyano-3-keto-10-methyl-octahydronaphthalene, C12H17NO, crystallizes in monoclinic space group P2...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....
C30H52O3, orthorhombic, P212121 (no. 19), a = 6.71147(14) Å, b = 16.6565(4) Å, c = 25.0815(6) Å, V =...
C33H41N3O2, orthorhombic, P212121 (no. 19), a = 8.44861(4) Å, b = 17.00722(9) Å, c = 20.1555(1) Å, V...
C29H54N2O3, monoclinic, P21 (no. 4), a = 9.8091(11) Å, b = 7.6661(8) Å, c = 19.095(2) Å, β = 93.171(...
The title compound, C30H48O2, contains a fused four-ring triterpenoid system. In the molecule, the t...
C24H18O3, monoclinic, P21/c (no. 14), a = 9.0474(7) Å, b = 19.9648(12) Å, c = 10.7153(3) Å, β = 104....
C17H20O2, monoclinic, P121/n1 (no. 14), a = 6.618(1) Å, b = 27.538(5) Å, c = 14.951(3) Å, β = 98.768...
C15H16O, monoclinic, P21/c (no. 14), a = 5.4371(7) Å, b = 17.567(2) Å, c = 11.8840(18) Å, β = 101.04...
C28H36FNO2, orthorhombic, P212121 (no. 19), a = 6.3277(3) Å, b = 11.9665(19) Å, c = 32.2419(19) Å, V...
C18H16O2, orthorhombic, Pnma (no. 62), a = 14.474(6) Å, b = 6.815(3) Å, c = 13.738(6) Å, V = 1355.1(...
C20H26O5, monoclinic, P21 (no. 4), a = 7.0011(5) Å, b = 12.3136(9) Å, c = 10.4847(8) Å, β = 105.734(...
C31H48O5, monoclinic, P21 (no. 4), a = 11.0421(3) Å, b = 6.49710(16) Å, c = 20.4687(4) Å, β = 97.922...
C32H50O3, orthorhombic, P212121 (no. 19), a = 8.0417(5) Å, b = 11.7996(6) Å, c = 30.1631(16) Å, V = ...
C15H16O2, triclinic, P1̄ (no. 2), a = 5.6034(7) Å, b = 8.7105(11) Å, c = 12.5661(16) Å, α = 92.790(7...
5α-cyano-3-keto-10-methyl-octahydronaphthalene, C12H17NO, crystallizes in monoclinic space group P2...
C15H16N4O, monoclinic, P21/c (no. 14), a = 10.3021(8) Å, b = 15.7835(13) Å, c = 8.3052(7) Å, β = 90....